Prescriber Resources
Key Points for Prescribers
- The prescriber enrolls and becomes certified with Lenalidomide REMS
- The prescriber counsels patient on benefits and risks of lenalidomide
- The prescriber provides contraception and emergency contraception counseling
- The prescriber verifies negative pregnancy test for all female patients of reproductive potential
- The prescriber completes a Lenalidomide REMS Patient-Physician Agreement Form with each patient and sends to Lenalidomide REMS
- The prescriber/patient completes applicable mandatory confidential survey
- The prescriber obtains an authorization number from Lenalidomide REMS and writes it on every prescription, along with the patient risk category
- The prescriber writes no more than a 4-week (28-day) supply, with no automatic refills or telephone prescriptions
- The prescriber sends lenalidomide prescription to certified pharmacy
Enrolling in Lenalidomide REMS
In order to prescribe lenalidomide, you must enroll in Lenalidomide REMS. You can enroll by visiting CelgeneRiskManagement.com, a website that allows prescribers to handle the REMS process for all of the REMS programs. You can also download the Prescriber Enrollment Form below and fax it to Lenalidomide REMS at 1-888-432-9325.
Prescribing lenalidomide for your patients
In order to receive lenalidomide, your patients must also be enrolled in Lenalidomide REMS. You can enroll your patients and fill out a prescription form using CelgeneRiskManagement.com. You and your patients can also complete your mandatory confidential surveys there.
Learning more about Lenalidomide REMS
For additional information about Lenalidomide REMS, please see the educational materials below.
Please report adverse drug experiences that are suspected to be associated with the use of lenalidomideand any suspected pregnancy occurring during the treatment with lenalidomide to Lenalidomide REMS using any of the following methods:
REPORTING TO Lenalidomide REMS | |
Online: | www.celgene.com/contact-us/ |
Email: | drugsafety@celgene.com |
Telephone: | 1-908-673-9667 |
Toll-free: | 1-800-640-7854 (Global Drug Safety & Risk Management) or 1-888-423-5436 (Lenalidomide REMS) |
Fax: | 1-908-673-9115 |
Mail to: | Global Drug Safety & Risk Management Celgene Corporation 86 Morris Avenue Summit, New Jersey 07901 |
REPORTING TO THE FDA | |
Adverse drug experiences that are suspected to be associated with the use of lenalidomide and any suspected pregnancy occurring during the treatment with lenalidomide may also be reported to the FDA MedWatch Reporting System using any of the following methods: | |
Online: | https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm |
Telephone: | 1-800-FDA-1088 |
Fax: | 1-800-FDA-0178 |
Mail to: | MedWatch 5600 Fishers Lane Rockville, MD 20852-9787 |